Sentence examples for Presently in development from inspiring English sources

Present work deals with morphological, microstructural, compositional and tribological characterisation of nanoscaled multilayer CrN/NbN coating produced by an industrial process presently in development phase.

A mission dedicated to simultaneous measurements of the solar diameter, spectral, and total solar irradiance is presently in development for launch end of the year 2008 on board of a microsatellite under the responsibility of Centre National d'Etudes Spatiales.

This objective is reached using analytical formulas which are presented in this paper, coupled to a Fortran code ESCORT (Electromagnetic Superconducting System for the Computation of Research Tokamaks), to be integrated into SYCOMORE, a code for reactor modelling presently in development at CEA/IRFM in Cadarache, using the tools of the EFDA Integrated Tokamak Modelling task force.

Web services providing real-time prediction capabilities based on SMILES-based structural inputs are presently in development, and the ability to draw a chemical structure in an entry web page as an input to all OPERA models is planned.

Inhibitors of the PI3K pathways are presently in development including specific inhibitors of p110alpha that have demonstrated efficacy in engineered preclinical models of lung cancer harboring activating point mutations in PIK3CA[ 27].

Even if tumor-specific effector cells are initially recruited into the tumor, the recruitment of Treg cells into the same site can result in an unproductive anti-tumor response, and this is believed to play a major part in the failure of many cancer immunotherapies presently in development [ 14, 18].

These editors are presently still in development stage, but clearly show the potential of JavaScript programming connected with browser-based graphics.

With adecatumumab (MT201), such a novel human IgG1 anti-EpCAM antibody is presently in clinical development (Naundorf et al, 2002).

Apremilast is presently in clinical development for the treatment of patients with several immune inflammatory conditions 1.

Three new anti-TB agents presently in the development pipeline (bedaquiline, delamanid, and PA-824) have the potential to enhance our capacity to cure XDR-TB.

The identification of endosialin as a HSC cell surface receptor that promotes fibrosis and reduces hepatocyte proliferation warrants the consideration of endosialin as a liver therapeutic target (which is presently in clinical development in oncologic settings).